keyword
MENU ▼
Read by QxMD icon Read
search

Laser and genitourinary syndrome of menopause

keyword
https://www.readbyqxmd.com/read/30252804/microablative-fractional-co2-laser-for-the-genitourinary-syndrome-of-menopause-up-to-12-month-results
#1
Stavros Athanasiou, Eleni Pitsouni, Themos Grigoriadis, Dimitris Zacharakis, Matthew E Falagas, Stefano Salvatore, Athanasios Protopapas, Dimitris Loutradis
OBJECTIVE: The aim of this study is to assess the efficacy of microablative fractional CO2 laser therapy for genitourinary syndrome of menopause (GSM) management, when three, four, or five laser therapies were applied in a follow-up period of 12 months. METHODS: Retrospective study evaluating GSM symptoms at baseline, and 1, 3, 6, and 12 months after last laser therapy. Visual analog scale, International Consultation on Incontinence Questionnaires- Female Urinary Tract Symptoms, International Consultation on Incontinence Questionnaires-Urinary Incontinence Short Form, Urogenital Distress Inventory-6, and Female Sexual Function Index were used for assessment of GSM symptoms' intensity or bothering and parameters of sexual function...
September 24, 2018: Menopause: the Journal of the North American Menopause Society
https://www.readbyqxmd.com/read/30241737/-co-2-laser-for-the-treatment-of-vaginal-symptoms-of-genitourinary-syndrome-of-menopause
#2
I Jardin, G Canlorbe, J-L Mergui, M Nikpayam, J Belghiti, C Uzan, H Azaïs
Genitourinary syndrome of menopause (GSM) brings together a collection of signs including vaginal dryness, burning sensation and itching discomfort as well as deterioration of sexual health, dysuria, urgenturia and repeated urinary infections and may be responsible for a significant impairment of quality of life in symptomatic postmenopausal women. The management of GSM therefore represents a public health issue. Systemic or local hormonal treatments are frequently offered, as well as non-hormonal treatments...
September 18, 2018: Gynecologie, Obstetrique, Fertilite & Senologie
https://www.readbyqxmd.com/read/30199815/an-innovative-dual-phase-protocol-for-pulsed-ablative-vaginal-erbium-yag-laser-treatment-of-urogynecological-symptoms
#3
Anke R Mothes, Marion Runnebaum, Ingo B Runnebaum
OBJECTIVES: To evaluate a dual-phase protocol for vaginal ablative Erbium:YAG laser treatment in pelvic floor medicine. STUDY DESIGN: Data from consecutive patients undergoing vaginal Erbium:YAG laser for first-degree pelvic floor complaints at a certified university urogynecological unit were analyzed. Fractional ablative and thermal treatment with adjustable pulse duration, fluence, and pulse interval was performed in single ten-minute treatment course. Followed up interval was 6 weeks including interviews on expectations, goal setting, goal achievement, and satisfaction (EGGS), vaginal pH, and determination of the Gloria-Bachmann-Index (VHI)...
October 2018: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://www.readbyqxmd.com/read/30124335/-long-term-effects-of-vaginal-erbium-laser-in-the-treatment-of-genitourinary-syndrome-of-menopause-pelvic-organ-prolapse-classification-issues
#4
Y-Y Liu, K-L Lin, C-Y Long
No abstract text is available yet for this article.
August 20, 2018: Climacteric: the Journal of the International Menopause Society
https://www.readbyqxmd.com/read/30117032/laser-therapy-for-genitourinary-syndrome-of-menopause
#5
REVIEW
Andrew Rabley, Tina O'Shea, Russell Terry, Sharon Byun, M Louis Moy
PURPOSE OF REVIEW: The purpose of this article is to review the available data regarding the application and therapeutic outcomes of laser therapy for the treatment of genitourinary syndrome of menopause (GSM). RECENT FINDINGS: There have been several studies regarding the use of laser therapy for the treatment of GSM. Most of these studies show a trend toward safe and effective treatment in the short term (less than or equal to 12 weeks). However, these studies are lacking in randomization, blinding, placebo, and comparison groups...
August 17, 2018: Current Urology Reports
https://www.readbyqxmd.com/read/30103082/efficacy-of-vaginal-therapies-alternative-to-vaginal-estrogens-on-sexual-function-and-orgasm-of-menopausal-women-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#6
REVIEW
Eleni Pitsouni, Themos Grigoriadis, Athanasios Douskos, Margarita Kyriakidou, Matthew E Falagas, Stavros Athanasiou
Genitourinary syndrome of menopause (GSM) increases the probability of female sexual dysfunction (FSD). The aim of the current study is to systematically assess data regarding sexual function and use of vaginal therapies, alternative to vaginal estrogens (VE), in menopausal women with GSM. PubMed, Scopus and Cochrane Library were searched (May-September 2017) using combination keywords: "dyspareunia and vaginal therapy", "sexual function and vaginal therapy", "orgasm and vaginal therapy", "vaginal atrophy" and "genitourinary syndrome of menopause"...
October 2018: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://www.readbyqxmd.com/read/29680080/no-358-intravaginal-laser-for-genitourinary-syndrome-of-menopause-and-stress-urinary-incontinence
#7
Jens-Erik Walter, Annick Larochelle
OBJECTIVE: This technical bulletin reviews the evidence relating to risks and benefits of using intravaginal laser technology in the management of genitourinary syndrome of menopause and stress urinary incontinence. INTENDED USERS: Gynaecologists, urogynaecologists, urologists, and other health care professionals who assess, counsel, and provide care for women with genitourinary syndrome of menopause and stress urinary incontinence. TARGET POPULATION: Adult women with genitourinary syndrome of menopause and stress urinary incontinence seeking complementary or alternative treatment options to topical estrogen, non-hormonal vaginal moisturizers, physiotherapy, intravaginal devices, and surgery...
April 2018: Journal of Obstetrics and Gynaecology Canada: JOGC, Journal D'obstétrique et Gynécologie du Canada: JOGC
https://www.readbyqxmd.com/read/29667744/intraurethral-erbium-yag-laser-for-the-management-of-urinary-symptoms-of-genitourinary-syndrome-of-menopause-a-pilot-study
#8
Adrian Gaspar, Sandra Maestri, Joaquin Silva, Hugo Brandi, Daniel Luque, Neža Koron, Zdenko Vižintin
OBJECTIVES: Genitourinary syndrome of menopause (GSM) combines the conditions of vulvovaginal atrophy (VVA) and urinary tract dysfunction, which is a result of urethral atrophy. There are several treatment methods available for the management of vulvovaginal symptoms of GSM, whereas urinary tract dysfunction often remains overlooked and undertreated. The objective of this pilot study was to assess the safety and efficacy of intraurethral Er:YAG laser treatment of urinary symptoms of GSM...
October 2018: Lasers in Surgery and Medicine
https://www.readbyqxmd.com/read/29492713/fractional-co-2-laser-for-genitourinary-syndrome-of-menopause-in-breast-cancer-survivors-clinical-immunological-and-microbiological-aspects
#9
Angelamaria Becorpi, Giuseppina Campisciano, Nunzia Zanotta, Zelinda Tredici, Secondo Guaschino, Felice Petraglia, Annalisa Pieralli, Giovanni Sisti, Francesco De Seta, Manola Comar
The composition of vaginal microbiome in menopause and cancer survivor women changes dramatically leading to genitourinary syndrome of menopause (GSM) in up to 70% of patients. Recent reports suggest that laser therapy may be valuable as a not hormonal therapeutic modality. The aim of the present study was to evaluate the effects of fractional CO2 laser treatment on the vaginal secretory pathway of a large panel of immune mediators, usually implicated in tissue remodeling and inflammation, and on microbiome composition in postmenopausal breast cancer survivors...
July 2018: Lasers in Medical Science
https://www.readbyqxmd.com/read/29487993/ablative-dual-phase-erbium-yag-laser-treatment-of-atrophy-related-vaginal-symptoms-in-post-menopausal-breast-cancer-survivors-omitting-hormonal-treatment
#10
A R Mothes, M Runnebaum, I B Runnebaum
PURPOSE: First evaluation of dual-phase vaginal Er:YAG laser to omit hormonal treatment for atrophy-related symptoms in post-menopausal breast cancer survivors following prolapse surgery. METHODS: Patients with a history of breast cancer at the time of surgery for pelvic organ prolapse were offered non-hormonal vaginal Er:YAG laser treatment when complaining of atrophy-related genitourinary syndrome of menopause. A single 10-min course of dual-phase protocol of pulsed Er:YAG laser (2940 nm, fractional ablative and thermal mode, fluence according to tissue thickness)...
May 2018: Journal of Cancer Research and Clinical Oncology
https://www.readbyqxmd.com/read/29436235/long-term-effects-of-vaginal-erbium-laser-in-the-treatment-of-genitourinary-syndrome-of-menopause
#11
M Gambacciani, M Levancini, E Russo, L Vacca, T Simoncini, M Cervigni
OBJECTIVES: To evaluate the long-term efficacy of a second generation of vaginal laser treatment, the vaginal erbium laser, as a non-ablative photothermal therapy for the management of genitourinary syndrome of menopause. METHODS: The study was performed using an erbium laser crystal yttrium-aluminum-garnet (XS Fotona Smooth™, Fotona, Ljubljana, Slovenia) with a wavelength of 2940 nm. Postmenopausal women (n = 205) were treated with three laser applications at 30-day intervals...
April 2018: Climacteric: the Journal of the International Menopause Society
https://www.readbyqxmd.com/read/29406425/vulvar-and-vaginal-fractional-co2-laser-treatments-for-genitourinary-syndrome-of-menopause
#12
Lauren F Streicher
Many healthcare providers are offering women treatment with the fractionated CO2 laser for a myriad of gynecologic issues, including genitourinary syndrome of menopause (GSM). Because existing data are limited, providing guidance is challenging. This Practice Pearl addresses what we know and don't know about the use of the fractionated CO2 laser for the treatment of GSM.
May 2018: Menopause: the Journal of the North American Menopause Society
https://www.readbyqxmd.com/read/29402732/female-sexual-dysfunction-a-systematic-review-of-outcomes-across-various-treatment-modalities
#13
REVIEW
James M Weinberger, Justin Houman, Ashley T Caron, Jennifer Anger
BACKGROUND: Female sexual dysfunction (FSD) is a highly prevalent condition. Nevertheless, the scientific literature has only recently begun to accumulate evidence for treatment modalities that address the underlying etiologies of FSD. AIM: The purpose of this systematic review is to elucidate what treatments are effective across the various symptom complexes of FSD. METHODS: Utilizing Meta-analysis of Observational Studies in Epidemiology guidelines, we conducted a systematic review of PubMed, EMBASE, clinicaltrials...
February 3, 2018: Sexual Medicine Reviews
https://www.readbyqxmd.com/read/29202940/genitourinary-syndrome-of-menopause-management-strategies-for-the-clinician
#14
REVIEW
Stephanie S Faubion, Richa Sood, Ekta Kapoor
Genitourinary syndrome of menopause (GSM), previously known as atrophic vaginitis or vulvovaginal atrophy, affects more than half of postmenopausal women. Caused by low estrogen levels after menopause, it results in bothersome symptoms, including vaginal dryness, itching, dyspareunia, urinary urgency and increased frequency, and urinary tract infections. Even though women with GSM can have sexual dysfunction that interferes with partner relationships, women are often embarrassed to seek treatment, and health care professionals do not always actively screen for GSM...
December 2017: Mayo Clinic Proceedings
https://www.readbyqxmd.com/read/29040373/nonsurgical-vulvovaginal-rejuvenation-with-radiofrequency-and-laser-devices-a-literature-review-and-comprehensive-update-for-aesthetic-surgeons
#15
Ali A Qureshi, Marissa M Tenenbaum, Terence M Myckatyn
Nonsurgical vulvovaginal rejuvenation (NVR) is growing in popularity as a treatment for restoration of youthful female genitalia. Numerous radiofrequency (RF) and laser devices have entered the market claiming improvement in vaginal laxity and genitourinary syndrome of menopause. There is a paucity of evidence existing concerning the effectiveness of these devices for both pre- and postmenopausal women with laxity and/or atrophy at the histologic and clinical level. Therefore, the goal of this review is to scrutinize the peer-reviewed data on NVR with RF and laser devices, identify gaps in existing literature, and propose opportunities for further investigation...
February 15, 2018: Aesthetic Surgery Journal
https://www.readbyqxmd.com/read/28923173/co-2-laser-for-the-genitourinary-syndrome-of-menopause-how-many-laser-sessions
#16
Stavros Athanasiou, Eleni Pitsouni, Matthew E Falagas, Stefano Salvatore, Themos Grigoriadis
OBJECTIVES: The aim of this prospective study was to assess the efficacy of 3, 4 or 5 CO2 -laser sessions for the management of the genitourinary syndrome of menopause (GSM). METHODS: Postmenopausal women with moderate to severe symptoms of dyspareunia, wanting to resume/retain sexual activity, were treated with 3-5 laser sessions depending on symptom severity/presence, sexual function, clinical findings and women's preference following the third laser application...
October 2017: Maturitas
https://www.readbyqxmd.com/read/28881431/fractional-co-2-laser-of-the-vagina-for-genitourinary-syndrome-of-menopause-is-the-out-of-pocket-cost-worth-the-outcome-of-treatment
#17
MULTICENTER STUDY
Patrick Lang, Jeffrey R Dell, Leonard Rosen, Peter Weiss, Mickey Karram
OBJECTIVES: The purpose of this study is to assess patient's satisfaction treatment outcomes and out-of-pocket expense for the fractional CO2 laser (SmartXide) in the treatment of genitourinary symptoms of menopause (GSM). MATERIALS AND METHODS: A multicenter retrospective cohort study of patients who completed a course of three vaginal treatments with the SmartXide11 Fractional CO2 laser. Patients contacted via telephone and asked to participate in questionnaires to evaluate for adverse outcomes since last treatment, symptom severity before and after treatment, patient satisfaction with treatment, patient satisfaction with out-of-pocket expense, and sexual function...
December 2017: Lasers in Surgery and Medicine
https://www.readbyqxmd.com/read/28843942/sexual-function-in-women-suffering-from-genitourinary-syndrome-of-menopause-treated-with-fractionated-co-2-laser
#18
REVIEW
Stefano Salvatore, Eleni Pitsouni, Fabio Del Deo, Marta Parma, Stavros Athanasiou, Massimo Candiani
INTRODUCTION: Genitourinary syndrome of menopause (GSM) has a significant impact on the trophism of the genital and lower urinary tracts and can considerably impair sexual function. Fractional CO2 laser has a regenerative effect on vulvovaginal tissue trophism after menopause. AIM: To review the available literature on the effect of fractional CO2 laser on the sexual function of postmenopausal women affected by GSM. METHODS: A database search was carried out using the terms CO2 laser, vaginal atrophy, sexual function, dyspareunia, and genitourinary syndrome of menopause and excluding studies using other types of laser or including breast cancer survivors with vulvovaginal atrophy...
October 2017: Sexual Medicine Reviews
https://www.readbyqxmd.com/read/28778337/laser-therapy-for-the-genitourinary-syndrome-of-menopause-a-systematic-review-and-meta-analysis
#19
REVIEW
Eleni Pitsouni, Themos Grigoriadis, Matthew E Falagas, Stefano Salvatore, Stavros Athanasiou
This study aimed to identify and then synthesize all available data regarding the efficacy of laser therapy for postmenopausal women with genitourinary syndrome of menopause (GSM) with/without urinary incontinence (UI). PubMed, Scopus, Web of Science, Cochrane Library and ClinicalTrials.gov were searched in October 2016. The keywords were "laser genitourinary syndrome of menopause", "laser vulvovaginal atrophy", "laser vaginal atrophy" and "laser women incontinence". Quality of reporting and risk of bias of the included studies were assessed according to STROBE and MINORs checklists, respectively...
September 2017: Maturitas
https://www.readbyqxmd.com/read/28770400/microablative-fractional-co-2-laser-for-the-genitourinary-syndrome-of-menopause-power-of-30-or-40-w
#20
Eleni Pitsouni, Themos Grigoriadis, Matthew Falagas, Angeliki Tsiveleka, Stefano Salvatore, Stavros Athanasiou
This retrospective case-control study aimed to compare 30 versus 40 W power of CO2 laser for the therapy of genitourinary syndrome of menopause (GSM). Postmenopausal women with severe intensity of dyspareunia and dryness were eligible to be included in this study. Primary outcomes were dyspareunia and dryness. Secondary outcomes were itching/burning, dysuria, frequency and urgency, Female Sexual Function Index (FSFI), vaginal maturation value (VMV), and Vaginal Health Index Score (VHIS). One laser therapy was applied every month for 3 months...
November 2017: Lasers in Medical Science
keyword
keyword
165498
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"